Article info
PDFOriginal research
PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer – results of a multicentre UK evaluation
- Correspondence to Dr Jessica Bate, Paediatric Oncology, Southampton Children's Hospital, Southampton, UK; jessica.bate1{at}nhs.net
Citation
PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer – results of a multicentre UK evaluation
Publication history
- Received May 10, 2022
- Accepted June 28, 2022
- First published July 8, 2022.
Online issue publication
October 19, 2022
Article Versions
- Previous version (8 July 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.